Protara Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-34.5M | $-35.1M | $596.0K | $10.4M |
| FY2022 | $-26.5M | $-26.6M | $120.0K | $6.7M |
| FY2023 | $-37.6M | $-37.6M | $45.0K | $6.1M |
| FY2024 | $-35.8M | $-35.9M | $63.0K | $4.1M |
| FY2025 | $-56.4M | $-56.5M | $94.0K | $3.8M |